| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8313268 | Clinica Chimica Acta | 2013 | 6 Pages |
Abstract
Higher serum concentrations of TNF-α, SCC and CA153 before therapy are independently associated with poor prognosis in patients with stage I and II disease. Combined usage of these three biomarkers allows efficient evaluation of outcomes in cervical cancer patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Juan Li, Hao Cheng, Pengjun Zhang, Zhennan Dong, Hong-li Tong, Jing-Dong Jackie Han, Fei Guo, Ya-ping Tian,